NASDAQ listed Alexion Pharmaceuticals is now under Algo Engine buy conditions.
May 6, 2020-Alexion Pharmaceuticals announced first quarter 2020 revenues of 1.bn, (27% increase on the same time last year).
You're not a member! Trial today
On a GAAP basis, diluted EPS in the quarter was $2.50, a 4 percent decrease versus the prior year.
Non-GAAP diluted EPS for the first quarter of 2020 was $3.22, a 35 percent increase versus the first quarter of 2019.
